Antagonists and inhibitors of lipid mediators in experimental inflammation of the cornea.

Abstract

In experimental immunogenic keratitis, provoked in rabbits by intracorneal injection of 20 microliters of human serum albumin (HSA), various anti-inflammatory agents were studied in their effects on corneal edema, neovascularisation and leukocyte infiltration. Prophylactic treatment with a corticosteroid completely prevented the occurrence of keratitis. Nonsteroidal anti-inflammatory drugs such as a cyclooxygenase inhibitor partly prevented neovascularisation and corneal edema, a lipoxygenase inhibitor, a leukotriene antagonist or platelet-activating factor (PAF)-antagonist BN 52021 partially prevented mainly leukocyte infiltration. Prophylactic topical treatment with the poly-unsaturated fatty acids eicosapentaenoic acid and columbinic acid or a dietary supplement with fish oil showed less symptoms of keratitis in all respects.

• Authors: N J van Haeringen, N L Verbey, J L van Delft
• Journal: Journal of ocular pharmacology (J Ocul Pharmacol) Vol. 9 Issue 4 Pg. 365-72 ( 1993) ISSN: 8756-3320 [Print] United States
• PMID: 8106842 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Chromones
• Diterpenes
• Ginkgolides
• Lactones
• Linolenic Acids
• Lipids
• Lipoxygenase Inhibitors
• Platelet Activating Factor
• SRS-A
• 5,9,12-octadecatrienoic acid
• SC 39070
• Suprofen
• Eicosapentaenoic Acid
• ginkgolide B
• Fluorometholone

Topics

• Animals
• Chromones (therapeutic use)
• Diterpenes
• Eicosapentaenoic Acid (therapeutic use)
• Fluorometholone (therapeutic use)
• Ginkgolides
• Keratitis (metabolism, prevention & control)
• Lactones (therapeutic use)
• Linolenic Acids (therapeutic use)
• Lipids (antagonists & inhibitors)
• Lipoxygenase Inhibitors (therapeutic use)
• Male
• Platelet Activating Factor (antagonists & inhibitors)
• Rabbits
• SRS-A (antagonists & inhibitors)
• Suprofen (therapeutic use)